List of Tables
Table 1. Global PCSK9 Antagonists Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global PCSK9 Antagonists Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global PCSK9 Antagonists Market Competitive Situation by Manufacturers in 2025
Table 4. Global PCSK9 Antagonists Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global PCSK9 Antagonists Sales Market Share by Manufacturers (2021–2026)
Table 6. Global PCSK9 Antagonists Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global PCSK9 Antagonists Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market PCSK9 Antagonists Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of PCSK9 Antagonists, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of PCSK9 Antagonists, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of PCSK9 Antagonists, Product Types and Applications
Table 12. Global Key Manufacturers of PCSK9 Antagonists, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PCSK9 Antagonists Companies by Tier (Tier 1, Tier 2, Tier 3), based on PCSK9 Antagonists Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PCSK9 Antagonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global PCSK9 Antagonists Sales by Region (K Units), 2021–2026
Table 18. Global PCSK9 Antagonists Sales Market Share by Region (2021–2026)
Table 19. Global PCSK9 Antagonists Sales by Region (K Units), 2027–2032
Table 20. Global PCSK9 Antagonists Sales Market Share by Region (2027–2032)
Table 21. Global PCSK9 Antagonists Revenue by Region (US$ Million), 2021–2026
Table 22. Global PCSK9 Antagonists Revenue Market Share by Region (2021–2026)
Table 23. Global PCSK9 Antagonists Revenue by Region (US$ Million), 2027–2032
Table 24. Global PCSK9 Antagonists Revenue Market Share by Region (2027–2032)
Table 25. North America PCSK9 Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America PCSK9 Antagonists Sales by Country (K Units), 2021–2026
Table 27. North America PCSK9 Antagonists Sales by Country (K Units), 2027–2032
Table 28. North America PCSK9 Antagonists Revenue by Country (US$ Million), 2021–2026
Table 29. North America PCSK9 Antagonists Revenue by Country (US$ Million), 2027–2032
Table 30. Europe PCSK9 Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe PCSK9 Antagonists Sales by Country (K Units), 2021–2026
Table 32. Europe PCSK9 Antagonists Sales by Country (K Units), 2027–2032
Table 33. Europe PCSK9 Antagonists Revenue by Country (US$ Million), 2021–2026
Table 34. Europe PCSK9 Antagonists Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific PCSK9 Antagonists Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific PCSK9 Antagonists Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific PCSK9 Antagonists Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific PCSK9 Antagonists Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific PCSK9 Antagonists Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America PCSK9 Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America PCSK9 Antagonists Sales by Country (K Units), 2021–2026
Table 42. Latin America PCSK9 Antagonists Sales by Country (K Units), 2027–2032
Table 43. Latin America PCSK9 Antagonists Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America PCSK9 Antagonists Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa PCSK9 Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa PCSK9 Antagonists Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa PCSK9 Antagonists Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa PCSK9 Antagonists Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa PCSK9 Antagonists Revenue by Country (US$ Million), 2027–2032
Table 50. Global PCSK9 Antagonists Sales (K Units) by Type (2021–2026)
Table 51. Global PCSK9 Antagonists Sales (K Units) by Type (2027–2032)
Table 52. Global PCSK9 Antagonists Sales Market Share by Type (2021–2026)
Table 53. Global PCSK9 Antagonists Sales Market Share by Type (2027–2032)
Table 54. Global PCSK9 Antagonists Revenue (US$ Million) by Type (2021–2026)
Table 55. Global PCSK9 Antagonists Revenue (US$ Million) by Type (2027–2032)
Table 56. Global PCSK9 Antagonists Revenue Market Share by Type (2021–2026)
Table 57. Global PCSK9 Antagonists Revenue Market Share by Type (2027–2032)
Table 58. Global PCSK9 Antagonists Price (US$/Unit) by Type (2021–2026)
Table 59. Global PCSK9 Antagonists Price (US$/Unit) by Type (2027–2032)
Table 60. Global PCSK9 Antagonists Sales (K Units) by Application (2021–2026)
Table 61. Global PCSK9 Antagonists Sales (K Units) by Application (2027–2032)
Table 62. Global PCSK9 Antagonists Sales Market Share by Application (2021–2026)
Table 63. Global PCSK9 Antagonists Sales Market Share by Application (2027–2032)
Table 64. Global PCSK9 Antagonists Revenue (US$ Million) by Application (2021–2026)
Table 65. Global PCSK9 Antagonists Revenue (US$ Million) by Application (2027–2032)
Table 66. Global PCSK9 Antagonists Revenue Market Share by Application (2021–2026)
Table 67. Global PCSK9 Antagonists Revenue Market Share by Application (2027–2032)
Table 68. Global PCSK9 Antagonists Price (US$/Unit) by Application (2021–2026)
Table 69. Global PCSK9 Antagonists Price (US$/Unit) by Application (2027–2032)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Sanofi PCSK9 Antagonists Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novartis PCSK9 Antagonists Product
Table 79. Novartis Recent Developments/Updates
Table 80. Amgen Company Information
Table 81. Amgen Description and Business Overview
Table 82. Amgen PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Amgen PCSK9 Antagonists Product
Table 84. Amgen Recent Developments/Updates
Table 85. Regeneron Pharmaceuticals Company Information
Table 86. Regeneron Pharmaceuticals Description and Business Overview
Table 87. Regeneron Pharmaceuticals PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Regeneron Pharmaceuticals PCSK9 Antagonists Product
Table 89. Regeneron Pharmaceuticals Recent Developments/Updates
Table 90. Innovent Biologics Company Information
Table 91. Innovent Biologics Description and Business Overview
Table 92. Innovent Biologics PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Innovent Biologics PCSK9 Antagonists Product
Table 94. Innovent Biologics Recent Developments/Updates
Table 95. Merck Company Information
Table 96. Merck Description and Business Overview
Table 97. Merck PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Merck PCSK9 Antagonists Product
Table 99. Merck Recent Developments/Updates
Table 100. Hasten Biopharmaceutical Company Information
Table 101. Hasten Biopharmaceutical Description and Business Overview
Table 102. Hasten Biopharmaceutical PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Hasten Biopharmaceutical PCSK9 Antagonists Product
Table 104. Hasten Biopharmaceutical Recent Developments/Updates
Table 105. Junshi Biosciences Company Information
Table 106. Junshi Biosciences Description and Business Overview
Table 107. Junshi Biosciences PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Junshi Biosciences PCSK9 Antagonists Product
Table 109. Junshi Biosciences Recent Developments/Updates
Table 110. Akeso Company Information
Table 111. Akeso Description and Business Overview
Table 112. Akeso PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Akeso PCSK9 Antagonists Product
Table 114. Akeso Recent Developments/Updates
Table 115. Jiangsu Hengrui Pharmaceuticals Company Information
Table 116. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 117. Jiangsu Hengrui Pharmaceuticals PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Jiangsu Hengrui Pharmaceuticals PCSK9 Antagonists Product
Table 119. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 120. Salubris Pharmaceuticals Company Information
Table 121. Salubris Pharmaceuticals Description and Business Overview
Table 122. Salubris Pharmaceuticals PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Salubris Pharmaceuticals PCSK9 Antagonists Product
Table 124. Salubris Pharmaceuticals Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. PCSK9 Antagonists Distributors List
Table 128. PCSK9 Antagonists Customers List
Table 129. PCSK9 Antagonists Market Trends
Table 130. PCSK9 Antagonists Market Drivers
Table 131. PCSK9 Antagonists Market Challenges
Table 132. PCSK9 Antagonists Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of PCSK9 Antagonists
Figure 2. Global PCSK9 Antagonists Market Value by Type (US$ Million), 2021–2032
Figure 3. Global PCSK9 Antagonists Market Share by Type: 2025 & 2032
Figure 4. Monoclonal Antibody Product Picture
Figure 5. siRNA Product Picture
Figure 6. Other Product Picture
Figure 7. Global PCSK9 Antagonists Market Value by Application (US$ Million), 2021–2032
Figure 8. Global PCSK9 Antagonists Market Share by Application: 2025 & 2032
Figure 9. Hypercholesterolemia
Figure 10. Atherosclerotic Cardiovascular Disease
Figure 11. Others
Figure 12. Global PCSK9 Antagonists Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global PCSK9 Antagonists Market Size (US$ Million), 2021–2032
Figure 14. Global PCSK9 Antagonists Sales (K Units), 2021–2032
Figure 15. Global PCSK9 Antagonists Average Price (US$/Unit), 2021–2032
Figure 16. PCSK9 Antagonists Report Years Considered
Figure 17. PCSK9 Antagonists Sales Share by Manufacturers in 2025
Figure 18. Global PCSK9 Antagonists Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global PCSK9 Antagonists Players: Market Share by Revenue in PCSK9 Antagonists in 2025
Figure 20. PCSK9 Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global PCSK9 Antagonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America PCSK9 Antagonists Sales Market Share by Country (2021–2032)
Figure 23. North America PCSK9 Antagonists Revenue Market Share by Country (2021–2032)
Figure 24. United States PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe PCSK9 Antagonists Sales Market Share by Country (2021–2032)
Figure 27. Europe PCSK9 Antagonists Revenue Market Share by Country (2021–2032)
Figure 28. Germany PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific PCSK9 Antagonists Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific PCSK9 Antagonists Revenue Market Share by Region (2021–2032)
Figure 35. China PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America PCSK9 Antagonists Sales Market Share by Country (2021–2032)
Figure 43. Latin America PCSK9 Antagonists Revenue Market Share by Country (2021–2032)
Figure 44. Mexico PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa PCSK9 Antagonists Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa PCSK9 Antagonists Revenue Market Share by Country (2021–2032)
Figure 50. Turkey PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE PCSK9 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of PCSK9 Antagonists by Type (2021–2032)
Figure 54. Global Revenue Market Share of PCSK9 Antagonists by Type (2021–2032)
Figure 55. Global PCSK9 Antagonists Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of PCSK9 Antagonists by Application (2021–2032)
Figure 57. Global Revenue Market Share of PCSK9 Antagonists by Application (2021–2032)
Figure 58. Global PCSK9 Antagonists Price (US$/Unit) by Application (2021–2032)
Figure 59. PCSK9 Antagonists Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
